Clinical Trials for Myeloma Multiple

Find clinical trials for myeloma multiple. Discover research opportunities and treatment options in your area.

11 Active Trials Found

Showing 11 trials on this page

Page 1 of 1

Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

NCT ID: NCT05091372

This clinical trial is studying a new treatment approach for patients with newly diagnosed multiple myeloma, a type of blood cancer, who have recently undergone a stem cell transplant. The goal is ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States, Houston, Texas, United States

Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS

NCT ID: NCT06559033

This clinical trial is looking to understand the genetic changes in patients with two specific conditions: Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS). Curre...

Not yet recruiting

Type: observational

The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors

NCT ID: NCT06911710

This clinical trial is exploring a new treatment called CAR-T cell therapy for patients with certain types of blood cancers, including aggressive lymphomas, acute myeloid leukemia (AML), and multip...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tianjin, Tianjin, China

A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

NCT ID: NCT04268199

**Trial Summary: Exploring Home Administration of Chemotherapy for Myeloma** This clinical trial is looking into whether patients with myeloma can safely give themselves a specific chemotherapy tr...

Recruiting

Phase: PHASE2 Type: interventional Locations: Edmonton, Alberta, Canada, Calgary, Alberta, Canada +1 more

The Norwegian Immunotherapy in Multiple Myeloma Study

NCT ID: NCT06855121

The Norwegian Immunotherapy in Multiple Myeloma Study is a research project looking at new treatments for multiple myeloma and related conditions, such as plasma cell leukemia and AL amyloidosis. T...

Recruiting

Type: observational Locations: Haugesund, , Norway, Stavanger, , Norway +21 more

Bioequivalence Studies of Dasatinib 100 Mg

NCT ID: NCT05944783

This clinical trial is designed to study Dasatinib, a medication used in treating multiple myeloma, by comparing two different formulations of the drug to see if they have the same effects in the b...

Not yet recruiting

Phase: PHASE4 Type: interventional Locations: Chia, Cundinamarca, Colombia

A Study of an MMSET Inhibitor in Patients with Relapsed and Refractory Multiple Myeloma

NCT ID: NCT05651932

This clinical trial is studying a new medication designed to treat adults with relapsed or refractory multiple myeloma, a type of blood cancer that has not responded to previous treatments. The dru...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Boston, Massachusetts, United States +27 more

Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

NCT ID: NCT06245629

This clinical trial is looking at two different treatment approaches for patients with relapsed multiple myeloma, which is a type of blood cancer. The trial will compare a new combination treatment...

Recruiting

Type: observational Locations: Uppsala, , Sweden

Limited-duration Teclistamab

NCT ID: NCT05932680

This clinical trial is studying a new approach to treating multiple myeloma, a type of blood cancer. The researchers want to find out if patients who have responded well to a medication called tecl...

Recruiting

Phase: PHASE2 Type: interventional Locations: Philadelphia, Pennsylvania, United States

Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients

NCT ID: NCT06133426

This clinical trial is looking at how well connected scales can help monitor patients with specific blood cancers, such as lymphoma and multiple myeloma, during their chemotherapy treatment. The st...

Not yet recruiting

Phase: NA Type: interventional

Evaluation of a Range of Dermo-cosmetic Products to Treat Skin and Nail Toxicity Linked to Bispecific Anti-GPRC5D Bispecific Antibodies in Multiple Myeloma Patients". Myeloma". Descriptive Pilot Study

NCT ID: NCT06418750

This clinical trial is looking at how well certain skincare and nail products can help patients with multiple myeloma (a type of blood cancer) manage skin and nail problems caused by a specific tre...

Not yet recruiting

Phase: NA Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions